| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Anatomy and Cell Biology, University of Illinois at Chicago, Chicago, Illinois 60680 [C. H. A.], and Cancer Center, University of Illinois at Chicago, Chicago, Illinois 60612 [C. W. B.]
Administration of the direct acting carcinogen N-methyl-N-nitrosourea (NMU) to 50-55-day-old virgin female rats on different days of the estrous cycle yields differential breast tumor biology (T. A. Ratko and C. W. Beattie, Cancer Res., 45: 30423047). One basis for these estrous cycle-dependent differences may be the duration of cell cycle stages of susceptible structures such as mammary terminal end buds or the quantity and duration of repair effected following adduct formation within these structures. The terminal end bud (TEB) epithelial cell cycle was characterized using pulse injections of [3H]thymidine (0.5 mCi/g body weight). On estrus, TEB epithelial cell cycle was significantly shorter (15.5 h) than on proestrus (19.9 h) and diestrus (18.8 h). The shorter duration in TEB cell cycle on estrus was likely due to a shorter TG1 (34 h) (P < 0.05) since TS and TG2 did not differ between estrous cycle days. When NMU was injected 1 h after [3H]thymidine, the labeled mitotic wave within TEB of diestrus rats recovered
23 h sooner than those given injections during proestrus (P < 0.01), suggesting less initial damage or a slightly faster rate of DNA adduct repair. When [3H]thymidine was injected 15 days after the NMU, the percentage of labeled mitoses of rats given injections during diestrus and proestrus recovered to near normal 48 h after NMU, although the proportion of all cells labeled was still low compared to non-NMU-treated rats. The percentage of labeled mitoses and labeling of cells were normal 3 and 5 days after NMU. Rats receiving a carcinogenic but sublethal dose of NMU (5 mg/100 g body weight), followed by [3H]thymidine injection within 1 min, had one-half the intensity of thymidine incorporation into the terminal end bud DNA of non-NMU-treated rats. Unscheduled DNA synthesis was not demonstrable within the first 48 h following injection of NMU. The results support and extend the finding that rat mammary epithelial cell carcinogenicity of NMU is estrous cycle dependent and appears to be correlated with a differential response in the cell cycle of TEB (shorter at estrus) or delayed recovery in response to NMU (proestrus versus diestrus).
1 Supported by Grant CN-62 from the American Cancer Society. This paper is dedicated to the memory of Moon-Chull Han, Ph.D.
2 To whom requests for reprints should be addressed.
3 Present address: United States Department of Agriculture, Animal Research Service, Meat Animal Research Center, Box 166, Clay Center, NE 68933.
Received 4/13/92. Accepted 7/ 7/92.
This article has been cited by other articles:
![]() |
A. Shilkaitis, A. Green, V. Steele, R. Lubet, G. Kelloff, and K. Christov Neoplastic transformation of mammary epithelial cells in rats is associated with decreased apoptotic cell death Carcinogenesis, February 1, 2000; 21(2): 227 - 233. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Engelbergs, J. Thomale, A. Galhoff, and M. F. Rajewsky Fast repair of O6-ethylguanine, but not O6-methylguanine, in transcribed genes prevents mutation of H-ras in rat mammary tumorigenesis induced by ethylnitrosourea in place of methylnitrosourea PNAS, February 17, 1998; 95(4): 1635 - 1640. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z Nikolova, V Djonov, G Zuercher, A. Andres, and A Ziemiecki Cell-type specific and estrogen dependent expression of the receptor tyrosine kinase EphB4 and its ligand ephrin-B2 during mammary gland morphogenesis J. Cell Sci., January 9, 1998; 111(18): 2741 - 2751. [Abstract] [PDF] |
||||
![]() |
R. Humphreys, M Krajewska, S Krnacik, R Jaeger, H Weiher, S Krajewski, J. Reed, and J. Rosen Apoptosis in the terminal endbud of the murine mammary gland: a mechanism of ductal morphogenesis Development, January 12, 1996; 122(12): 4013 - 4022. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |